- Recommendation ID
- NG238/1
- Question
What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on statins for primary prevention of CVD .
Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects.
Source guidance details
- Comes from guidance
- Cardiovascular disease: risk assessment and reduction, including lipid modification
- Number
- NG238
- Date issued
- December 2023
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 01/01/2024 |